ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,616 | -18.9% | 116,658 | +1.6% | 0.00% | – |
| Q2 2023 | $851,883 | +68.1% | 114,809 | +114.0% | 0.00% | – |
| Q1 2023 | $506,917 | -19.3% | 53,642 | -9.1% | 0.00% | – |
| Q4 2022 | $628,468 | +44.5% | 59,011 | 0.0% | 0.00% | – |
| Q3 2022 | $435,000 | +77.6% | 59,011 | +16.2% | 0.00% | – |
| Q2 2022 | $245,000 | -5.4% | 50,793 | 0.0% | 0.00% | – |
| Q1 2022 | $259,000 | -15.1% | 50,793 | 0.0% | 0.00% | – |
| Q4 2021 | $305,000 | -32.2% | 50,793 | 0.0% | 0.00% | – |
| Q3 2021 | $450,000 | +11.9% | 50,793 | 0.0% | 0.00% | – |
| Q2 2021 | $402,000 | +3.9% | 50,793 | 0.0% | 0.00% | – |
| Q1 2021 | $387,000 | -10.8% | 50,793 | -8.8% | 0.00% | – |
| Q4 2020 | $434,000 | +5.3% | 55,665 | +30.9% | 0.00% | – |
| Q3 2020 | $412,000 | – | 42,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intrepid Financial Planning Group LLC | 18,000 | $106,560 | 0.06% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $71,040 | 0.04% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 16,625 | $98,420 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $378,679 | 0.01% |
| Brandywine Global Investment Management, LLC | 174,500 | $1,033,040 | 0.01% |
| J. Goldman & Co LP | 13,500 | $79,920 | 0.00% |
| ROYCE & ASSOCIATES LP | 50,000 | $296,000 | 0.00% |
| Retirement Group, LLC | 1,191 | $7,051 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 14,550 | $86,136 | 0.00% |
| Hartford Financial Management Inc. | 598 | $3,541 | 0.00% |